ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

KM

Kravira Medical Centre at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Kravira Medical Centre takes part in 4 sessions at ESMO 2026 in Madrid. Its research focuses on prostate cancer biology, treatment trials and precision oncology. Studies examine vimentin and hormone-receptor expression in prostate tumours, alongside trial control groups and clinicians’ learning needs in genetic testing.

OrganizationESMO 2026 Attendance
KM
Kravira Medical Centre
Minsk, Belarus
Cancer centre & hospital
Medical centre in Minsk, Belarus.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Characteristics of vimentin (Vim) expression in prostate cancer (PCa)
ePoster session 17
Genitourinary cancers
Poster
Fri Oct 23
13:00–15:00
Poster
Sun Oct 25
12:00–12:45
Control arms in ongoing randomised controlled trials evaluating systemic therapies for prostate cancer
Sunday Poster Display session 6
Genitourinary cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Kravira Medical Centre

Tell us what you sell and we’ll find the people at Kravira Medical Centre most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction